Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Ryan, Noss"'
Publikováno v:
Journal of Investigative Medicine High Impact Case Reports, Vol 8 (2020)
Thrombocytopenia 2 (THC2) is an autosomal dominant disorder characterized by ankyrin repeat domain 26 mutation and moderate thrombocytopenia. THC2 exposes patients to a low risk of bleeding and an increased likelihood of myelodysplastic syndrome/acut
Externí odkaz:
https://doaj.org/article/f2e093c1fe5648a7a2f02b16554d1a67
Autor:
Debra T. Linfield, Michael B. Rothberg, Elizabeth R. Pfoh, Ryan Noss, Lydia Cassard, Joseph C. Powers, Laura Lipold, Kathryn A. Martinez
Publikováno v:
Breast Cancer Research and Treatment. 195:153-160
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::81470f34db5930ecaebcbb1406b11993
https://doi.org/10.1007/s10549-022-06523-5
https://doi.org/10.1007/s10549-022-06523-5
Publikováno v:
Health and Technology. 12:839-844
Telegenetics is the use of telemedicine to deliver clinical genetic services to patients. During the COVID-19 public health emergency (PHE), telegenetics was essential for the Center of Personalized Genetic Healthcare (CPGH). This study reviews and a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae008412badfba031242d4ee595b53ed
https://doi.org/10.1007/s12553-022-00670-x
https://doi.org/10.1007/s12553-022-00670-x
Autor:
Ryan Noss, Holly J. Pederson
Publikováno v:
Seminars in Oncology. 47:182-186
Testing for hereditary predisposition to breast cancer is rapidly expanding in parallel with the emerging field of molecular genetics given the associated implications for screening, risk reduction and cancer therapeutics for identified gene mutation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e65d5f7e8c5cd22e762842d6de74b05
https://doi.org/10.1053/j.seminoncol.2020.05.008
https://doi.org/10.1053/j.seminoncol.2020.05.008
Autor:
Debra T, Linfield, Michael B, Rothberg, Elizabeth R, Pfoh, Ryan, Noss, Lydia, Cassard, Joseph C, Powers, Laura, Lipold, Kathryn A, Martinez
Publikováno v:
Breast cancer research and treatment. 195(2)
The United States Preventive Services Task Force recommends primary care physicians refer patients at high risk for BRCA1/2 mutations to genetic testing when appropriate. The objective of our study was to describe referrals for BRCA1/2 testing in a l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c2c7f3e2c03ba08ae158dc16e9121c8e
https://pubmed.ncbi.nlm.nih.gov/35842521
https://pubmed.ncbi.nlm.nih.gov/35842521
Publikováno v:
Journal of Genetic Counseling. 28:962-973
Genetic counseling assistants (GCAs) have the potential to address the high demand for genetic counselors by promoting task-sharing, increasing genetic counselor efficiency, and allowing for higher level duties to be optimized by genetic counselors.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::689f2eb24712ff60559ff64b6aa73bde
https://doi.org/10.1002/jgc4.1148
https://doi.org/10.1002/jgc4.1148
Publikováno v:
Journal of Investigative Medicine High Impact Case Reports
Thrombocytopenia 2 (THC2) is an autosomal dominant disorder characterized by ankyrin repeat domain 26 mutation and moderate thrombocytopenia. THC2 exposes patients to a low risk of bleeding and an increased likelihood of myelodysplastic syndrome/acut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8bdb73e509e7ff1f85518f2936d108cb
https://pubmed.ncbi.nlm.nih.gov/32618208
https://pubmed.ncbi.nlm.nih.gov/32618208
Autor:
Stephen R. Grobmyer, Courtney Yanda, Dharmesh Gopalakrishnan, Charis Eng, Ryan Noss, Holly J. Pederson
Publikováno v:
Journal of the American College of Surgeons. 226:560-565
With the advent of multigene panel testing for breast cancer patients, germline mutations with unknown association with cancer risk, known as variants of uncertain significance (VUS), are being increasingly identified. Some studies have shown higher
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5745518c9f87b89b3b95c4e23b02453
https://doi.org/10.1016/j.jamcollsurg.2017.12.037
https://doi.org/10.1016/j.jamcollsurg.2017.12.037
Autor:
Timothy J. Moss, Amy Shealy, J. Kevin Hicks, Allison Schreiber, Ryan Noss, Marvin R. Natowicz, Charis Eng, Angelika Erwin, Marissa Coleridge, Rocio Moran
Publikováno v:
Clinical and Translational Science. 11:71-76
Whole exome sequencing (WES) has the potential of identifying secondary findings that are predictive of poor pharmacotherapy outcomes. The purpose of this study was to investigate patients’ wishes regarding the reporting of secondary pharmacogenomi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2ce6d77a845b2762818615e99cabc54b
https://doi.org/10.1111/cts.12493
https://doi.org/10.1111/cts.12493
Publikováno v:
Journal of Genetic Counseling. 23:671-678
This study explored whether genetic counseling programs are incorporating instruction about the applications and techniques of predictive genomic testing (PGT) based on student recollection, and whether this is perceived as adequate by those students
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e30db83c6dbb94425b31d52d43646a76
https://doi.org/10.1007/s10897-014-9699-2
https://doi.org/10.1007/s10897-014-9699-2